Forxiga_12_04_PR_antidiabetic

First Page		Document Content
Date: 2013-07-21 06:30:06 Health Dapagliflozin Diabetes mellitus Anti-diabetic medication Insulin Hyperglycemia SLC5A2 European Medicines Agency Diabetes Endocrine system Medicine		Forxiga_12_04_PR_antidiabetic Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 74,92 KB Share Document on Facebook

	DOCX Document DocID: 17hG7 - View Document
	CLINICAL SGLT2 inhibition with dapagliflozin Gary Kilov Stephen Leow DocID: 1465v - View Document
	Microsoft Word - final_150414_e.docx DocID: 13VvB - View Document
	License Agreement of SGLT2 Inhibitor “CSG452” in Japan DocID: ZwJo - View Document
	Forxiga_12_04_PR_antidiabetic DocID: RJQ3 - View Document